CryoPort Inc

NASDAQ:CYRX   3:59:45 PM EDT
52.92
+1.28 (+2.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.41B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$46.78 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$52.27
50-Day MA$57.71
200-Day MA$49.60
See more pivots

CryoPort, Inc. Stock, NASDAQ:CYRX

112 Westwood Place, Suite 350, Brentwood, Tennessee 37027
United States of America
Phone: +1.949.470.2300
Number of Employees: 125

Description

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.